Authorizes insurance policies which provide coverage for prescription drugs where cost-sharing obligations are determined by category of prescription drugs to offer a program to insureds that utilizes rebates or discounts to lower an insured's cost-sharing for prescription drugs if the insured's cost-sharing under such program would be more favorable than the cost-sharing that would otherwise be applicable to the prescription drug.

This bill allows insurance companies in New York to create programs that use rebates or discounts to help lower the out-of-pocket costs for prescription drugs for insured individuals. If these programs offer better cost-sharing options than the standard ones, insured individuals can benefit from reduced payments when they purchase their medications. Essentially, it aims to make prescription drugs more affordable for patients based on the type of medication they need.

Supporters of this bill would highlight its potential to significantly reduce the financial burden of prescription drugs on patients. They would argue that by allowing insurance companies to offer rebates and discounts, more individuals will have access to necessary medications at a lower cost, ultimately improving public health outcomes.

Critics might argue that this bill could complicate the insurance process and lead to confusion among consumers regarding their prescription drug costs. They may also express concerns that relying on rebates and discounts could mask the true prices of medications, preventing meaningful reform in drug pricing and transparency.